World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 97 832 761 28 27 497 30344
Medicine 98 8996 8444 270 264 544 31224

Andrew R. Lloyd publications per year

The chart shows the history of publications by Andrew R. Lloyd between 1987 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Andrew R. Lloyd published across 39 years, from 1987 to 2025, averaging 17.4 papers a year. Output peaked at 40 publications in 2025. 76 of the 679 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1987 to 2025. Vertical axis: number of publications, 0 to 40. Peak 40 publications in 2025. 1987: 5 publications 1988: 10 publications 1989: 4 publications 1990: 7 publications 1991: 6 publications 1992: 6 publications 1993: 11 publications 1994: 19 publications 1995: 11 publications 1996: 10 publications 1997: 9 publications 1998: 13 publications 1999: 11 publications 2000: 11 publications 2001: 9 publications 2002: 9 publications 2003: 9 publications 2004: 14 publications 2005: 8 publications 2006: 16 publications 2007: 16 publications 2008: 11 publications 2009: 7 publications 2010: 20 publications 2011: 16 publications 2012: 34 publications 2013: 26 publications 2014: 28 publications 2015: 38 publications 2016: 33 publications 2017: 31 publications 2018: 15 publications 2019: 24 publications 2020: 21 publications 2021: 25 publications 2022: 30 publications 2023: 30 publications 2024: 36 publications 2025: 40 publications
1987 2025

679 publications in total across all disciplines

View publications per year as a table
Andrew R. Lloyd: publications per year, 1987 to 2025
Year Publications
1987 5
1988 10
1989 4
1990 7
1991 6
1992 6
1993 11
1994 19
1995 11
1996 10
1997 9
1998 13
1999 11
2000 11
2001 9
2002 9
2003 9
2004 14
2005 8
2006 16
2007 16
2008 11
2009 7
2010 20
2011 16
2012 34
2013 26
2014 28
2015 38
2016 33
2017 31
2018 15
2019 24
2020 21
2021 25
2022 30
2023 30
2024 36
2025 40
Total 679
Download as CSV

Andrew R. Lloyd publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Andrew R. Lloyd sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 492–501 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 497 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30 497
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Andrew R. Lloyd D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew R. Lloyd sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 96–97 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 97 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66 97
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Andrew R. Lloyd is affiliated with the University of New South Wales in Australia. Their research activity is primarily situated in the field of Medicine, with notable contributions across several subfields including Epidemiology, Infectious Diseases, Hepatology, Public Health, Environmental and Occupational Health, and Immunology.

The scientist's research topics focus considerably on viral infections and their medical implications. Main areas of work encompass:

  • Hepatitis C virus research
  • Hepatitis B virus studies
  • HIV, drug use, and sexual risk
  • SARS-CoV-2 and COVID-19 research
  • Liver disease diagnosis and treatment
  • Mosquito-borne diseases and control
  • COVID-19 clinical research studies

Frequent collaborators include Rowena A. Bull, Jason Grebely, Gregory J. Dore, Chaturaka Rodrigo, and Behzad Hajarizadeh.

Publication venues where Andrew R. Lloyd has contributed frequently comprise:

  • International Journal of Drug Policy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • Journal of Hepatology
  • Scientific Reports

Selected recent papers include:

  • "Long COVID and Post-infective Fatigue Syndrome: A Review," 2021, published in Open Forum Infectious Diseases
  • "Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial," 2023, published in The Lancet Oncology
  • "Prevalence and Characteristics Associated With Post-COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults," 2023, published in JAMA Network Open
  • "Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study," 2021, published in The Lancet. Gastroenterology & Hepatology
  • "Chronic fatigue syndrome: progress and possibilities," 2020, published in The Medical Journal of Australia

Best Publications

  • Recombinant Human Interferon-inducible Protein 10 Is a Chemoattractant for Human Monocytes and T Lymphocytes and Promotes T Cell Adhesion to Endothelial Cells

    Dennis D. Taub;Andrew R. Lloyd;Kevin Conlon;Ji Ming Wang

  • Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study

    Ian Hickie;Tracey Davenport;Denis Wakefield;Ute Vollmer-Conna

  • Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta

    Dennis D. Taub;Kevin Conlon;Andrew R. Lloyd;Joost J. Oppenheim

  • Estimating progression to cirrhosis in chronic hepatitis C virus infection.

    Anthony J. Freeman;Gregory J. Dore;Matthew G. Law;Max Thorpe

  • Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes.

    Raffaele Badolato;Ji Ming Wang;William J Murphy;Andrew R. Lloyd

  • Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response

    Andrew R Lloyd;Joost J Oppenheim

  • Prevalence of chronic fatigue syndrome in an Australian population.

    A R Lloyd;I Hickie;C R Boughton;O Spencer

  • Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution.

    William C Reeves;Andrew Lloyd;Suzanne D Vernon;Nancy Klimas

  • The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

    Jason Grebely;Kimberly A Page;Rachel Sacks-Davis;Martin Schim van der Loeff

  • Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis

    A Masi;D S Quintana;N Glozier;A R Lloyd

  • Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes

    M Kawamura;D W McVicar;J A Johnston;T B Blake

  • Longitudinal study of outcome of chronic fatigue syndrome

    Andrew Wilson;Ian Hickie;Andrew Lloyd;Dusan Hadzi-Pavlovic

  • The psychiatric status of patients with the chronic fatigue syndrome.

    Ian Hickie;Andrew Lloyd;Denis Wakefield;Gordon Parker

  • The role of cytokines in the pathogenesis of inflammatory eye disease

    Denis Wakefield;Andrew Lloyd

  • Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation.

    Charles E. Harvey;Jeffrey J. Post;Patricia Palladinetti;Anthony J. Freeman

  • Sequential bottlenecks drive viral evolution in early acute Hepatitis C virus infection

    Rowena A. Bull;Fabio Luciani;Kerensa McElroy;Silvana Gaudieri

  • Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine

    Jason Grebely;Maria Prins;Margaret Hellard;Andrea L Cox

  • CCR5 Expression Correlates with Susceptibility of Maturing Monocytes to Human Immunodeficiency Virus Type 1 Infection

    Hassan M. Naif;Shan Li;Mohammed Alali;Andrew Sloane

  • Immunological abnormalities in the chronic fatigue syndrome.

    Andrew R. Lloyd;Denis Wakefield;Clement R. Boughton;John M. Dwyer

  • Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans.

    U. Vollmer-Conna;C. Fazou;B. Cameron;H. Li

  • Chemokines and serpentines: the molecular biology of chemokine receptors.

    David J. Kelvin;Dennis F. Michiel;James A. Johnston;Andrew R. Lloyd

Frequent Co-Authors

Gregory J. Dore
Gregory J. Dore University of New South Wales
Denis Wakefield
Denis Wakefield University of New South Wales
Jason Grebely
Jason Grebely University of New South Wales
Margaret Hellard
Margaret Hellard Burnet Institute
Ian B. Hickie
Ian B. Hickie University of Sydney
Gail V. Matthews
Gail V. Matthews University of New South Wales
William D. Rawlinson
William D. Rawlinson University of New South Wales
Lisa Maher
Lisa Maher University of New South Wales
John M. Kaldor
John M. Kaldor University of New South Wales
Maria Prins
Maria Prins University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare fields, especially nursing. For those looking to advance their nursing credentials while focusing on immunological health, bridge programs offer a flexible, online option. For example, an fnp to acnp bridge program online allows Family Nurse Practitioners to transition to Acute Care Nurse Practitioners, opening doors to more specialized patient care.

Accelerated programs can speed up your entry into advanced nursing roles. Many students benefit from an accelerated fnp pathway, which condenses essential coursework and clinical experience into a shorter timeframe without sacrificing quality.

For individuals without a nursing background interested in immunology-related healthcare roles, online absn programs for non nurses provide an accessible entry point. These programs are designed to build foundational nursing skills while accommodating the schedules of working professionals.

Moreover, admission to nursing programs can vary widely. Those seeking less competitive entry options might explore absn programs with high acceptance rates, which offer a strategic pathway into nursing careers connected to immunology research and patient care.

Best Scientists Citing Andrew R. Lloyd

Trending Scientists

Recently Published Articles